 | • レポートコード：MRC2303F0141 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、225ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療機器 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査レポートは、2021年に212.68百万ドルであった世界の臍帯血処理＆保存装置市場規模が、2022年に251.87百万ドルになり、2027年まで年平均18.68%で成長して594.43百万ドルに拡大すると予測しています。本レポートでは、臍帯血処理＆保存装置の世界市場について調査し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、種類別（自動、半自動）分析、治療別（抗拒絶薬/免疫抑制剤、抗ウイルス剤、化学療法剤、コルチコステロイド、ワクチン）分析、用途別（貧血、自閉症、脳性まひ、糖尿病、白血病）分析、エンドユーザー別（病院、研究機関、専門クリニック）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの項目を掲載しています。また、主要企業として、Americord Registry LLC、CBR Systems, Inc.、CORDLIFE GROUP LIMITED、Cordlife India、Cryo-Cell International, Inc.、FamiCord Group、Global Cord Blood Corporation、LifeCell International Pvt. Ltd.、Singapore Cord Blood Bank Limited、StemCyte Inc.、ViaCord, LLC、Vita 34 AGなどの企業情報を含んでいます。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の臍帯血処理＆保存装置市場規模：種類別 - 自動臍帯血処理＆保存装置の市場規模 - 半自動臍帯血処理＆保存装置の市場規模 ・世界の臍帯血処理＆保存装置市場規模：治療別 - 抗拒絶薬/免疫抑制剤の市場規模 - 抗ウイルス剤の市場規模 - 化学療法剤の市場規模 - コルチコステロイドの市場規模 - ワクチンの市場規模 ・世界の臍帯血処理＆保存装置市場規模：用途別 - 貧血における市場規模 - 自閉症における市場規模 - 脳性まひにおける市場規模 - 糖尿病における市場規模 - 白血病における市場規模 ・世界の臍帯血処理＆保存装置市場規模：エンドユーザー別 - 病院における市場規模 - 研究機関における市場規模 - 専門クリニックにおける市場規模 ・世界の臍帯血処理＆保存装置市場規模：地域別 - 南北アメリカの臍帯血処理＆保存装置市場規模 アメリカの臍帯血処理＆保存装置市場規模 カナダの臍帯血処理＆保存装置市場規模 ブラジルの臍帯血処理＆保存装置市場規模 ... - アジア太平洋の臍帯血処理＆保存装置市場規模 日本の臍帯血処理＆保存装置市場規模 中国の臍帯血処理＆保存装置市場規模 インドの臍帯血処理＆保存装置市場規模 韓国の臍帯血処理＆保存装置市場規模 台湾の臍帯血処理＆保存装置市場規模 ... -ヨーロッパ/中東/アフリカの臍帯血処理＆保存装置市場規模 イギリスの臍帯血処理＆保存装置市場規模 ドイツの臍帯血処理＆保存装置市場規模 フランスの臍帯血処理＆保存装置市場規模 ロシアの臍帯血処理＆保存装置市場規模 ... -その他地域の臍帯血処理＆保存装置市場規模 ・競争状況 ・企業情報 |
The Global Cord Blood Processing & Storage Equipment Market size was estimated at USD 212.68 million in 2021 and expected to reach USD 251.87 million in 2022, and is projected to grow at a CAGR 18.68% to reach USD 594.43 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Cord Blood Processing & Storage Equipment to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the market was studied across Automated and Semi-Automated.
Based on Treatment Type, the market was studied across Anti-Rejection Drugs/Immunosuppressants, Antiviral Drugs, Chemotherapy Drugs, Corticosteroids, IImmunoglobulins, Targeted Therapy, and Vaccines.
Based on Application, the market was studied across Anemia, Autism, Cerebral Palsy, Diabetes, Leukemia, and Thalassemia.
Based on End-user, the market was studied across Hospitals, Research Institutes, and Specialty Clinics.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Cord Blood Processing & Storage Equipment market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cord Blood Processing & Storage Equipment Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Cord Blood Processing & Storage Equipment Market, including Americord Registry LLC, CBR Systems, Inc., CORDLIFE GROUP LIMITED, Cordlife India, Cryo-Cell International, Inc., FamiCord Group, Global Cord Blood Corporation, LifeCell International Pvt. Ltd., Singapore Cord Blood Bank Limited, StemCyte Inc., ViaCord, LLC, and Vita 34 AG.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Cord Blood Processing & Storage Equipment Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cord Blood Processing & Storage Equipment Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cord Blood Processing & Storage Equipment Market?
4. What is the competitive strategic window for opportunities in the Global Cord Blood Processing & Storage Equipment Market?
5. What are the technology trends and regulatory frameworks in the Global Cord Blood Processing & Storage Equipment Market?
6. What is the market share of the leading vendors in the Global Cord Blood Processing & Storage Equipment Market?
7. What modes and strategic moves are considered suitable for entering the Global Cord Blood Processing & Storage Equipment Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of life-threatening genetic diseases
5.1.1.2. Government initiatives and growing clinical trials in regenerative medicines
5.1.1.3. Rising awareness about therapeutic applications of cord blood
5.1.2. Restraints
5.1.2.1. High cost of processing and storage equipment
5.1.3. Opportunities
5.1.3.1. Automated technology for cord blood banking
5.1.3.2. Expansion of public and private cord blood stem cell banking
5.1.4. Challenges
5.1.4.1. Lack of uniformity in regulatory policies
5.2. Cumulative Impact of COVID-19
6. Cord Blood Processing & Storage Equipment Market, by Type
6.1. Introduction
6.2. Automated
6.3. Semi-Automated
7. Cord Blood Processing & Storage Equipment Market, by Treatment Type
7.1. Introduction
7.2. Anti-Rejection Drugs/Immunosuppressants
7.3. Antiviral Drugs
7.4. Chemotherapy Drugs
7.5. Corticosteroids
7.6. IImmunoglobulins
7.7. Targeted Therapy
7.8. Vaccines
8. Cord Blood Processing & Storage Equipment Market, by Application
8.1. Introduction
8.2. Anemia
8.3. Autism
8.4. Cerebral Palsy
8.5. Diabetes
8.6. Leukemia
8.7. Thalassemia
9. Cord Blood Processing & Storage Equipment Market, by End-user
9.1. Introduction
9.2. Hospitals
9.3. Research Institutes
9.4. Specialty Clinics
10. Americas Cord Blood Processing & Storage Equipment Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Cord Blood Processing & Storage Equipment Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Cord Blood Processing & Storage Equipment Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Americord Registry LLC
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. CBR Systems, Inc.
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. CORDLIFE GROUP LIMITED
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Cordlife India
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Cryo-Cell International, Inc.
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. FamiCord Group
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Global Cord Blood Corporation
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. LifeCell International Pvt. Ltd.
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Singapore Cord Blood Bank Limited
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. StemCyte Inc.
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. ViaCord, LLC
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Vita 34 AG
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing